Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07453-0Source: DataRank Database

Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018 is a research paper published in Breast Cancer Research and Treatment (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: greenTopics (32)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Cody Ramin ORCID,Jacqueline B. Vo ORCID,Heather Spencer Feigelson ORCID,Jennifer C. Gander ORCID,Lene H. S. Veiga ORCID

Live enrichment

PubMed:39148003 PMC:PMC12510238

US National Cancer Institute

Grant: HHSN 261201800469PP0, HHSN 261201700708P, HHSN 261201600711P, 1R01CA1205621, P01CA154292, HHSN 261201700564P, HHSN75N91019P00076, HHSN 5N910200327, HHSN 61201400010I, HHSN261201800043C, N01-CN-67009, N01-PC-35142, R50CA211115

Division of Cancer Epidemiology and Genetics

Grant: Intramural Research Program

RTI International

Grant: HHSN 26120090017C

NCI NIH HHS

Grant: P01 CA154292

NCI NIH HHS

Grant: R50 CA211115

NCI NIH HHS

Grant: N01 PC035142

NCI NIH HHS

Grant: N01 CN067009

NCI NIH HHS

Grant: R01 CA120562

National Institutes of Health

Grant: 2P01CA154292-11

Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice

National Institutes of Health

Grant: 7R50CA211115-02

Group Health Cancer Research Program Research Specialist Award

National Institutes of Health

Grant: N01CN067009-004

SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAM

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12510238/pdf/nihms-2115335.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-024-07453-0.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-024-07453-0/fulltext.html

https://doi.org/10.1007/s10549-024-07453-0

https://pubmed.ncbi.nlm.nih.gov/39148003

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansCarcinoma, Intraductal, NoninfiltratingBreast NeoplasmsTamoxifenReceptors, EstrogenAntineoplastic Agents, HormonalAromatase InhibitorsRetrospective StudiesAdultAgedAged, 80 and overMiddle AgedFemale

Keywords

Estrogen receptorBreast cancerTamoxifenDcisAromatase Inhibitors AdultAged, 80 and overAntineoplastic Agents, HormonalBreast NeoplasmsMiddle AgedArticleCarcinoma, Intraductal, NoninfiltratingReceptors, EstrogenHumansFemaleAgedRetrospective Studies

Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018

FAIR Checklist

Authors (11)

Funding (11 grants)

Open Access

Topics

Annotations (Europe PMC)